Positive News SentimentPositive NewsNASDAQ:HHS Harte Hanks (HHS) Stock Price, News & Analysis $2.83 +0.02 (+0.71%) As of 11:35 AM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Harte Hanks Stock (NASDAQ:HHS) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Harte Hanks alerts:Sign Up Key Stats Today's Range$2.76▼$2.7650-Day Range$2.30▼$2.9452-Week Range$2.22▼$5.39Volume278 shsAverage Volume8,553 shsMarket Capitalization$20.98 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview Harte-Hanks, Inc. engages in the provision of marketing solutions. It specializes in consulting, data analytics, creative services, digital and social media, marketing strategy, marketing technology, and other related services. It supports a range of customers in the field of technology, travel and leisure, entertainment, pharmaceuticals, automotive, finance, and retail. The company was founded in 1923 and is headquartered in San Antonio, TX. Read More Harte Hanks Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks5th Percentile Overall ScoreHHS MarketRank™: Harte Hanks scored higher than 5% of companies evaluated by MarketBeat, and ranked 294th out of 301 stocks in the business services sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.7 / 5Analyst RatingSell Consensus RatingHarte Hanks has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoverageHarte Hanks has only been the subject of 1 research reports in the past 90 days.Read more about Harte Hanks' stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Harte Hanks is -25.55, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Harte Hanks is -25.55, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioHarte Hanks has a P/B Ratio of 1.01. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.67% of the float of Harte Hanks has been sold short.Short Interest Ratio / Days to CoverHarte Hanks has a short interest ratio ("days to cover") of 9.89.Change versus previous monthShort interest in Harte Hanks has recently decreased by 18.65%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthWeak Dividend YieldHarte Hanks does not currently pay a dividend.Dividend GrowthHarte Hanks does not have a long track record of dividend growth.Read more about Harte Hanks' dividend. News and Social Media0.0 / 5News SentimentN/A News Coverage This WeekMarketBeat has tracked 1 news article for Harte Hanks this week, compared to 0 articles on an average week. Company Ownership0.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Harte Hanks insiders have not sold or bought any company stock.Percentage Held by Insiders9.60% of the stock of Harte Hanks is held by insiders.Percentage Held by Institutions33.75% of the stock of Harte Hanks is held by institutions.Read more about Harte Hanks' insider trading history. Receive HHS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Harte Hanks and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. HHS Stock News HeadlinesWe're Not Worried About Harte Hanks' (NASDAQ:HHS) Cash BurnFebruary 13, 2026 | finance.yahoo.comHarte Hanks Reports Q3 2025 Results Amid New PartnershipsNovember 11, 2025 | msn.comIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of the world's oil passing through that corridor, crude has already crossed $100 per barrel. History shows gold surged 571% during the 1973 oil crisis and 425% in 1979. Today, the U.S. holds 8,133 tonnes of gold valued on the books at $42.22 per ounce - while gold trades above $5,000. American Alternative Assets has released The Great Gold Reset report detailing what this gap could mean for investors.May 12 at 1:00 AM | American Alternative (Ad)Harte Hanks, Inc.: Harte Hanks Reports Third Quarter 2025 ResultsNovember 10, 2025 | finanznachrichten.deInsider Buyers Lose Additional US$156k As Harte Hanks Dips To US$26mOctober 30, 2025 | finance.yahoo.comReturns At Harte Hanks (NASDAQ:HHS) Are On The Way UpOctober 3, 2025 | uk.finance.yahoo.comCompanies Like Harte Hanks (NASDAQ:HHS) Could Be Quite RiskySeptember 6, 2025 | finance.yahoo.comHarte Hanks Second Quarter 2025 Earnings: US$0.045 loss per share (vs US$3.84 loss in 2Q 2024)August 10, 2025 | finance.yahoo.comSee More Headlines HHS Stock Analysis - Frequently Asked Questions How have HHS shares performed this year? Harte Hanks' stock was trading at $3.01 at the beginning of the year. Since then, HHS shares have decreased by 6.6% and is now trading at $2.81. How were Harte Hanks' earnings last quarter? Harte Hanks, Inc. (NASDAQ:HHS) announced its earnings results on Tuesday, March, 17th. The business services provider reported $0.30 earnings per share for the quarter. The business services provider earned $39.86 million during the quarter. Harte Hanks had a negative net margin of 0.51% and a negative trailing twelve-month return on equity of 3.86%. Who are Harte Hanks' major shareholders? Harte Hanks' top institutional shareholders include Krilogy Financial LLC (1.59%). Insiders that own company stock include Brian Linscott, John H Griffin Jr, Kirk A Davis and David A Garrison. View institutional ownership trends. How do I buy shares of Harte Hanks? Shares of HHS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Harte Hanks own? Based on aggregate information from My MarketBeat watchlists, some other companies that Harte Hanks investors own include NVIDIA (NVDA), Broadcom (AVGO), Adobe (ADBE), Meta Platforms (META), Arista Networks (ANET), GE Aerospace (GE) and Abercrombie & Fitch (ANF). Company Calendar Last Earnings3/17/2026Today5/12/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (37m+) 1-Year History May 25 Aug 25 Nov 25 Feb 26 May 26 HHS's financial health is in the Red zone, according to TradeSmith. HHS has been in this zone for over 37 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorBusiness Services Industry Direct mail advertising services Sub-IndustryAdvertising Current SymbolNASDAQ:HHS CIK45919 Webwww.hartehanks.com Phone(512) 434-1100Fax210-829-9139Employees2,069Year FoundedN/AProfitability EPS (Trailing Twelve Months)($0.11) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$810 thousand Net Margins-0.51% Pretax Margin-0.63% Return on Equity-3.86% Return on Assets-0.85% Debt Debt-to-Equity RatioN/A Current Ratio1.54 Quick Ratio1.54 Sales & Book Value Annual Sales$159.57 million Price / Sales0.13 Cash Flow$0.49 per share Price / Cash Flow5.71 Book Value$2.77 per share Price / Book1.00Miscellaneous Outstanding Shares7,415,000Free Float6,703,000Market Cap$20.58 million OptionableNot Optionable Beta-0.03 Analysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2026 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free Report This page (NASDAQ:HHS) was last updated on 5/12/2026 by MarketBeat.com Staff. From Our PartnersTrump is positioned. Elon lights the fuse.On Thursday, the Senate Banking Committee votes on the CLARITY Act. A bill that would create the first real le...Crypto 101 Media | SponsoredIran broke the petrodollar…For 50 years, every barrel of oil settled in dollars - that rule is what made the dollar the world's reserve c...Golden Portfolio | SponsoredPeptide Company Lands Exclusive MMA Wellness PartnershipA publicly traded peptide company just signed an exclusive partnership with a NYSE-listed MMA media platform t...The Tomorrow Investor | SponsoredBSEM: From OTC to Nasdaq Contender!BioStem Technologies (OTC: BSEM) has posted seven consecutive profitable quarters and just released audited fi...Huge Alerts | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...American Alternative | SponsoredNevada gold explorer near Kinross district draws attentionGold has surged past $5,300 per ounce, with Goldman Sachs and JPMorgan forecasting $6,000+ by end of 2026. Cen...Wall Street Logic | SponsoredALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Harte Hanks, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Harte Hanks With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HHS Stock Alerts